GLUE vs DMAC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DMAC Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DiaMedica Therapeutics Inc. Common Stock (DMAC) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while GLUE counters with relative strength in Valuation. Fundamentally, GLUE trades at 10.0x Forward P/E with -214.5% operating margin (+325.8% YoY revenue) versus DMAC at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, GLUE sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro) against DMAC sits in SURGE (14th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | GLUE Revenue | DMAC Revenue | GLUE Op. Margin | DMAC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $0M | N/A | -1352.2% | DMAC |
| FY2024 | $80M | N/A | -107.3% | N/A | GLUE |
| FY2025 | $120M | N/A | -43.8% | N/A | GLUE |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GLUE | DMAC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $795.5M | $503.1M | Larger Scale | GLUE |
| Trailing P/E Ratio Valuation | 10.0x | N/M | Lower Multiple | GLUE |
| Forward P/E Ratio Valuation | 10.0x | N/M | Lower Multiple | GLUE |
| Revenue Growth (YoY) Growth | +325.8% | +0.0% | Higher Growth | GLUE |
| Operating Margin (TTM) Profitability | -214.5% | 0.0% | Higher Margin | DMAC |
| Net Profit Margin Profitability | -186.2% | 0.0% | Higher Margin | DMAC |
| Return on Equity (ROE) Capital Efficiency | -35.3% | -114.6% | Higher ROE | GLUE |
| 52-Week Range Position Momentum | 1% ($9โ$26) | 55% ($5โ$11) | Stronger Trend | DMAC |
| Beta / 30D Volatility Risk Regime | 0.94ฮฒ ยท 53% Vol | 1.74ฮฒ ยท 98% Vol | Lower Realized Risk | GLUE |
| Unified Institutional Score Composite Signal | 44.2 / 100 (HOLD) | 46.3 / 100 (HOLD) | Higher Composite | DMAC |